OverviewSuggest Edit

Establishment Labs, a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The Company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue.
TypePublic
Founded2004
HQAlajuela, CR
Websiteestablishmentlabs.com
Employee Ratings3.6
Overall CultureF

Latest Updates

Employees (est.) (Dec 2021)521(-18%)
Revenue (FY, 2020)$84.7 M(-5%)
Share Price (Jan 2022)$54.3
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Establishment Labs

Juan José Chacón-Quirós

Juan José Chacón-Quirós

CEO & Founder
Nick Lewin

Nick Lewin

Chairman
Salvador Dada

Salvador Dada

COO
Roberto de Mezerville

Roberto de Mezerville

Chief Technology Officer
Alberto Quesada

Alberto Quesada

VP of Quality & Regulatory
Olivier Tourniaire

Olivier Tourniaire

VP of Sales Asia Pacific, Middle East & Africa
Show more

Establishment Labs Office Locations

Establishment Labs has offices in Alajuela and Santa Barbara
Alajuela, CR (HQ)
4th Street, Coyol Free Zone
Santa Barbara, CA, US
1187 Coast Village Rd 1 402
Show all (4)

Establishment Labs Financials and Metrics

Establishment Labs Revenue

Embed Graph
View revenue for all periods
Establishment Labs's revenue was reported to be $84.68 m in FY, 2020
USD

Revenue (Q1, 2021)

30.3m

Gross profit (Q1, 2021)

20.1m

Gross profit margin (Q1, 2021), %

66.2%

Net income (Q1, 2021)

(6.9m)

EBIT (Q1, 2021)

(2.1m)

Market capitalization (24-Jan-2022)

1.3b

Closing stock price (24-Jan-2022)

54.3

Cash (31-Mar-2021)

78.0m

EV

1.3b
Establishment Labs's current market capitalization is $1.3 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

61.2m89.6m84.7m

Cost of goods sold

25.1m34.7m32.2m

Gross profit

36.1m54.9m52.5m

Gross profit Margin, %

59%61%62%
Quarterly
USDQ2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Revenue

13.7m16.3m21.7m22.9m24.5m10.5m30.3m

Cost of goods sold

5.5m6.2m8.7m8.6m9.0m3.2m10.2m

Gross profit

8.2m10.1m13.0m14.2m15.5m7.2m20.1m

Gross profit Margin, %

60%62%60%62%63%69%66%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

52.6m37.7m84.5m

Accounts Receivable

17.6m22.8m19.1m

Prepaid Expenses

4.3m6.8m5.4m

Inventories

24.8m28.7m23.2m
Quarterly
USDQ2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Cash

11.6m65.6m31.9m42.6m93.6m86.4m78.0m

Accounts Receivable

16.2m18.2m21.3m22.0m21.6m17.1m23.8m

Prepaid Expenses

4.3m5.6m4.5m7.0m7.2m3.8m4.2m

Inventories

13.2m15.4m26.5m26.4m25.5m29.1m22.4m
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

(21.1m)(38.1m)(38.1m)

Inventories

(7.0m)(3.4m)4.8m

Accounts Payable

(3.9m)1.8m(910.0k)

Cash From Operating Activities

(33.9m)(30.0m)(12.5m)
Quarterly
USDQ2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Net Income

(10.6m)(19.8m)(32.6m)(17.8m)(28.2m)(6.9m)

Inventories

(1.0m)(3.3m)(725.0k)(2.0m)438.0k(3.2m)(698.0k)

Accounts Payable

(487.0k)(2.5m)2.4m3.7m366.0k(1.3m)(617.0k)

Cash From Operating Activities

(14.9m)(25.4m)(15.1m)(26.0m)(6.8m)(12.9m)(6.6m)
USDQ2, 2018

Revenue/Employee

31.3k

Debt/Equity

9.1 x

Debt/Assets

0.3 x

Financial Leverage

26.7 x
Show all financial metrics

Establishment Labs Operating Metrics

FY, 2017FY, 2018

Countries

6060

Motiva Implants Sold to Date

446 k650 k

Product Lines

33
Show all operating metrics

Establishment Labs Acquisitions / Subsidiaries

Company NameDateDeal Size
Establishment Labs
Establishment Labs Produtos par Saude Ltda
European Distribution Center Motiva BVBA
JAMM Technologies
JEN-Vault AG
Motiva Implants France SAS
Motiva Implants Spain
Motiva Implants UK Limited
Motiva Italy S.R.L
Motiva Nordica AB
Show more

Establishment Labs Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Establishment Labs Online and Social Media Presence

Embed Graph

Establishment Labs Company Culture

  • Overall Culture

    F

    43/100

  • CEO Rating

    F

    10/100

  • Compensation

    D

    55/100

Learn more on Comparably

Establishment Labs News and Updates

Establishment Labs Completes 21 Motiva Mia Patients in IRB Approved Study in Costa Rica

SANTA BARBARA, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it recently received Institutional Review Board (IRB) appr…

Establishment Labs to Participate in Two Upcoming Investment Conferences

SANTA BARBARA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its participation in two investment conferences this month…

Establishment Labs Celebrates 10 Years of Motiva Safety Data

SANTA BARBARA, Calif., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, is today announcing its latest clinical data demonstrating 10 years of out…

Establishment Labs Finalizes Distribution Agreement with Puregraft LLC

SANTA BARBARA, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has finalized an amendment to its distribution agreeme…

Establishment Labs Announces Independent Publication Detailing New Advancements in Hybrid Breast Reconstruction Technique Using Motiva Ergonomix Implants

SANTA BARBARA, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that a recently published independent study concluded tha…

Establishment Labs to Announce Second Quarter 2020 Financial Results on August 6

NEW YORK, July 23, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended June 30, 2020 after the m…
Show more

Establishment Labs Blogs

Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue

Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue Content Import Mon, 01/10/2022 - 08:03 Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue January 10, 2022 This release is…

Establishment Labs to Present at the 40th Annual J.P. Morgan Healthcare Conference

Establishment Labs to Present at the 40th Annual J.P. Morgan Healthcare Conference Content Import Mon, 01/03/2022 - 08:01 Establishment Labs to Present at the 40th Annual J.P. Morgan Healthcare Conference January 3, 2022 This release is a ba…

Establishment Labs Announces Appointment of Raj Denhoy as Chief Financial Officer

Establishment Labs Announces Appointment of Raj Denhoy as Chief Financial Officer Content Import Mon, 12/13/2021 - 08:02 Establishment Labs Announces Appointment of Raj Denhoy as Chief Financial Officer December 13, 2021 This release is a ba…

Establishment Labs Announces Appointment of Leslie Gillin to Board of Directors

Establishment Labs Announces Appointment of Leslie Gillin to Board of Directors Content Import Fri, 12/10/2021 - 08:01 Establishment Labs Announces Appointment of Leslie Gillin to Board of Directors December 10, 2021 This release is a backfi…

Establishment Labs Announces Participation in the Stephens Annual Investment Conference

SANTA BARBARA, Calif. --(BUSINESS WIRE)--Nov. 24, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós,

Establishment Labs Announces Participation in Two Upcoming Investment Conferences

SANTA BARBARA, Calif. --(BUSINESS WIRE)--Nov. 11, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming
Show more

Establishment Labs Frequently Asked Questions

  • When was Establishment Labs founded?

    Establishment Labs was founded in 2004.

  • Who are Establishment Labs key executives?

    Establishment Labs's key executives are Juan José Chacón-Quirós, Nick Lewin and Salvador Dada.

  • How many employees does Establishment Labs have?

    Establishment Labs has 521 employees.

  • What is Establishment Labs revenue?

    Latest Establishment Labs annual revenue is $84.7 m.

  • What is Establishment Labs revenue per employee?

    Latest Establishment Labs revenue per employee is $162.5 k.

  • Who are Establishment Labs competitors?

    Competitors of Establishment Labs include GC Aesthetics, Bioventus and Nordson Medical.

  • Where is Establishment Labs headquarters?

    Establishment Labs headquarters is located at 4th Street, Coyol Free Zone, Alajuela.

  • Where are Establishment Labs offices?

    Establishment Labs has offices in Alajuela and Santa Barbara.

  • How many offices does Establishment Labs have?

    Establishment Labs has 4 offices.